Un estudio internacional con participación de la oncóloga del ICO L'Hospitalet, Sonia Pernas, muestra que el 'camizestrante' duplica el tiempo sin progresión de la enfermedad.
Read moreLos resultados, que han sido presentados en la edición de este año de la AACR y más recientemente de ASCO, muestran una mejora significativa de supervivencia y apuntan hacia un nuevo estándar de t...
Read moreThe IDIBAPS research group Systemic vasculitis, led by Maria C. Cid, has published a new study in the journal Annals of the Rheumatic Diseases that explores the mechanisms of action of the drug Tocili...
Read moreEn el caso del tacrolimus, recientemente se ha descrito su posible actividad como compuesto neuroregenerador neuronal y nervioso, la cual se está probando actualmente en diferentes laboratorios inter...
Read morePregnant women living with HIV accept dihydroartemisinin-piperaquine (DHA-PPQ) as an intermittent preventive treatment against malaria when recommended by healthcare providers
Read moreEl estudio global fase 3 MANEUVER de pimicotinib en TGCT ha alcanzado su objetivo primario al mostrar una tasa de respuesta objetiva a la semana 25 del 54,0 % frente al 3,2 % con placebo (p<0,0001)
Read moreThe phase 2 international multicenter SUNNIFORECAST study is the first prospective randomized trial evaluating dual immunotherapy with ipilimumab plus nivolumab against standard-of-care (SOC) tyrosine...
Read moreA clinical trial involving the Germans Trias i Pujol Research Institute and Hospital demonstrates that administering selumetinib reduces the tumour and the associated pain.
Read moreThe project was one of those selected in this competitive call, which aims to support the development of innovative preclinical studies to test a new drug for CADASIL. Thanks to this grant, CADASIMUS ...
Read moreLos investigadores comprobaron que ambos medicamentos, la N-acetilcisteína y el raloxifeno, reducen los niveles de TGF-beta1, una molécula clave en la resistencia al tratamiento, al estimular en los...
Read moreThe deeptech company DevsHealth, a member of Catalonia.health, and the Foundation for the Research of Neglected Diseases (FNDR), based in India, announce the identification of DHFLV_003B, the first an...
Read moreThe BOHEMIA trial, the largest study on ivermectin for malaria to date, showed a 26% reduction in new malaria infection on top of existing bed nets, providing strong evidence of ivermectin’s potenti...
Read more